RI H7042 | 2018 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on January 3 2018 - 25% progression, died in committee
Action: 2018-02-13 - Committee recommended measure be held for further study
Pending: House Corporations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 3 2018 - 25% progression, died in committee
Action: 2018-02-13 - Committee recommended measure be held for further study
Pending: House Corporations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Directs the state board of pharmacy to annually develop a list of critical prescription drugs for which there is a substantial public interest in understanding the development of the drugs’ price.
Title
Pharmacies
Sponsors
| Rep. Aaron Regunberg [D] | Rep. Lauren Carson [D] | Rep. Gregg Amore [D] | Rep. Patricia Serpa [D] |
| Rep. James McLaughlin [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-02-13 | House | Committee recommended measure be held for further study |
| 2018-02-09 | House | Scheduled for hearing and/or consideration (02/13/2018) |
| 2018-01-29 | House | Committee transferred to House Corporations |
| 2018-01-03 | House | Introduced, referred to House H.E.W. |
Subjects
Rhode Island State Sources
| Type | Source |
|---|---|
| Summary | https://status.rilegislature.gov/ |
| Text | https://webserver.rilegislature.gov/BillText18/HouseText18/H7042.pdf |
